Aspire Biopharma Holdings, Inc. (ASBP)
About Aspire Biopharma Holdings, Inc.
Aspire Biopharma Holdings Inc is an early-stage biopharmaceutical company focused on developing and commercializing novel sublingual drug delivery technologies. The company is mainly engaged in advancing patent-pending formulations designed to enable rapid absorption of drugs, initially targeting high-dose aspirin products for cardiovascular and pain management applications. Its technology aims to improve efficacy and response time by bypassing the gastrointestinal tract through sublingual delivery.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $6.2K
- Net income
- -$24.5M
- Total assets
- $1.3M
- Market cap
- $6.9M
- Operating margin
- -312016.9%
- Net margin
- -394725.1%
Source: SEC EDGAR · updated Jun 8, 2026
Financial statements
Income statement
- Revenue
- $6.2K
- Operating expenses
- $19.4M
- Operating income
- -$19.4M
- Net income
- -$24.5M
- EPS (diluted)
- $-16.38
Balance sheet
- Total assets
- $1.3M
- Current assets
- $1.3M
- Total liabilities
- $7.7M
- Current liabilities
- $7.6M
- Shareholders’ equity
- -$6.4M
Cash flow
- Operating cash flow
- -$4.9M
- Investing cash flow
- -$1.0M
- Financing cash flow
- $5.9M
- Net cash flow
- $0
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $6.9M
- EPS (diluted)
- $-16.38
- Shares outstanding
- 952.7K
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Feb 20, 2025
Aspire Biopharma Holdings, Inc. (ASBP) Stock Price
- Reported a net loss of $24.5M in FY2025.
- Trading 99% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Aspire Biopharma Holdings, Inc..
Write a review
News about Aspire Biopharma Holdings, Inc.
News & sentiment via Polygon.io
Aspire Biopharma Holdings, Inc.: frequently asked questions
Is Aspire Biopharma Holdings, Inc. an American company?
Aspire Biopharma Holdings, Inc. is a US-based company headquartered in Estero, Florida, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Aspire Biopharma Holdings, Inc. headquartered?
Aspire Biopharma Holdings, Inc. is headquartered in Estero, Florida, United States.
Is Aspire Biopharma Holdings, Inc. publicly traded?
Yes — Aspire Biopharma Holdings, Inc. is a publicly traded company. Its stock trades under the ticker symbol ASBP on the NASDAQ.
What does Aspire Biopharma Holdings, Inc. do?
Aspire Biopharma Holdings, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
